Page 246 - FINAL PROGRAMME 2017

P-390 Reduced pregnancy rates after intra-uterine insemination (IUI) in Human Papillomavirus (HPV) positive couples
C. Depuydt1, J. Beert2, D. Vanden Broeck1, G. Salembier1, E. Bosmans1, A. Cox3, E. Vandormael3, W. Ombelet3
1AML- Sonic Healthcare, Clinical and Molecular Pathology, Antwerp, Belgium
2AML- Sonic Healthcare, Intermediate structure human body material, Antwerp, Belgium
3Genk Institute for fertility technology GIFT VZW, Zorgprogramma Reproductieve Geneeskunde B ZRGB, Genk, Belgium
P-391 Proteomic and peptidomic analysis of human follicular uid by mass spectrometry as a potential tool for oocyte quality differentiation
A. Lewandowska1, K. Macur1, P. Czaplewska1, J. Liss2, K. Łukaszuk2,3, S. Ołdziej1
1University of Gdańsk, Intercollegiate Faculty of Biotechnology, Gdańsk, Poland
2Invicta, Reproduction and Fertility Centre, Gdańsk, Poland
3Medical University of Gdańsk, Department of Obstetrics and Gynecological Nursing, Gdańsk, Poland
P-392 In vitro fertilization outcomes in women with mullerian anomalies: revisiting the controversy
M. Dviri1, Y. Baruch1, E. Zohav1, Y. Hasson1, F. Azem1
1Tel Aviv Sourasky Medical Center, Sara Racine IVF Unit- Department of Obstetrics and Gynecology, Tel aviv, Israel
P-393 Could embryo banking be used as a treatment strategy in the management of poor responders?
H. Exeter1, V. Seshadri2, E. Drew1, A. Petrie3, P. Serhal4
1The Centre for Reproductive and Genetic Health, Embryology, London, United Kingdom 2The Centre of Reproductive and Genetic Health, Clinical, London, United Kingdom 3University College London, Biostastics, London, United Kingdom
4The Centre for Reproductive and Genetic Health, Medical Director, London, United Kingdom
P-394 Pituitary suppression protocol does affect clinical outcomes in egg donation cycles
V. Vergara Bravo1, M. Cruz2, E. Goyri3, A. Requena3 1IVI Madrid, Madrid, Spain
2IVI Madrid, IVF Laboratory, Madrid, Spain
3IVI MAdrid, Gynecology, Madrid, Spain
P-395 Real-life costs and effectiveness of contraceptive methods: a cohort study in the French national healthcare insurance database
T. Linet1, C. Godard2, C. Laurendeau3, A. Benmahmoud-Zoubir2, A. Lafuma3, L. Lévy-Bachelot2, J. Gourmelen4, A. Agostini5
1Centre Hospitalier Loire Vendée Océan, Gynécology-Obstétrics, Challans, France
2MSD, Haut-de-Seine, Courbevoie, France
3Cemka-Eval, Haut-de-Seine, Bourg-la-Reine, France
4INSERM, Unité Cohortes épidémiologiques en population - UMS 011 INSERM-UVSQ, Villejuif, France 5Hôpital de la Conception, Gynecology Obstetrics, Marseille, France,
246